The O O O O
following O O O O
are O O O O
the O O O O
proposed O O O O
treatment O O O O
protocols O O O O
for O O O O
childhood O O O O
CNS O O O O
vasculitis O O O O
and O O O O
inflammatory O O O O
brain O O O O
diseases O O O O
which O O O O
may O O O O
be O O O O
useful O O O O
for O O O O
physicians. O O O O
- O O O O
Angiography-positive Reason 3 O O
non-progressive Reason 3 O O
CNS Reason 3 O O
Vasculitis Reason 3 O O
(NP-cPACNS) Reason 3 O O
affects Reason 3 O O
medium-large Reason 3 O O
sized Reason 3 O O
vessels Reason 3 O O
and Reason 3 O O
the Reason 3 O O
diagnosis Reason 3 O O
is Reason 3 O O
confirmed Reason 3 O O
on Reason 3 O O
angiography. Reason 3 O O
It Reason 3 O O
is Reason 3 O O
a Reason 3 O O
monophasic Reason 3 O O
disease. Reason 3 O O
Children O O O O
with O O O O
NP-cPACNS O O O O
typically O O O O
present O O O O
arterial O O O O
ischemic O O O O
Vasculitis O O O O
(AP-cPACNS) O O O O
affects O O O O
medium-large O O O O
sized O O O O
vessels O O O O
and O O O O
the O O O O
diagnosis O O O O
is O O O O
confirmed O O O O
on O O O O
angiography. O O O O
When O O O O
untreated, O O O O
children O O O O
with O O O O
P-cPACNS O O O O
will O O O O
acquire O O O O
new O O O O
neurological O O O O
deficits O O O O
and O O O O
new O O O O
areas O O O O
of O O O O
stenosis O O O O
on O O O O
angiography O O O O
after O O O O
three O O O O
months. O O O O
[AP-cPACNS O O O O
suggested O O O O
treatment O O O O
protocol](/sites/default/files/teams/310/2022_Primary%20CNS%20Vasculitis.pdf) O O O O
- O O O O
Angiography-negative Reason 3 O O
CNS Reason 3 O O
Vasculitis Reason 3 O O
(SV-cPACNS) Reason 3 O O
affects Reason 3 O O
small Reason 3 O O
sized Reason 3 O O
vessels, Reason 3 O O
and Reason 3 O O
the Reason 3 O O
diagnosis Reason 3 O O
is Reason 3 O O
confirmed Reason 3 O O
on Reason 3 O O
brain Reason 3 O O
biopsy. Reason 3 O O
Children O O O O
with O O O O
SV-cPACNS O O O O
present O O O O
with O O O O
predominantly O O O O
diffuse O O O O
neurological O O O O
deficits. O O O O
[SV-cPACNS O O O O
suggested O O O O
treatment O O O O
protocol](/sites/default/files/teams/310/2022_Primary%20CNS%20Vasculitis.pdf) O O O O
- O O O O
Antibody Reason 3 O O
Mediated Reason 3 O O
Inflammatory Reason 3 O O
Brain Reason 3 O O
Diseases Reason 3 O O
(IBrainD) Reason 3 O O
represent Reason 3 O O
a Reason 3 O O
novel Reason 3 O O
group Reason 3 O O
of Reason 3 O O
diseases Reason 3 O O
in Reason 3 O O
which Reason 3 O O
inflammation Reason 3 O O
targets Reason 3 O O
the Reason 3 O O
brain Reason 3 O O
structure Reason 3 O O
in Reason 3 O O
previously Reason 3 O O
healthy Reason 3 O O
children Reason 3 O O
and Reason 3 O O
causes Reason 3 O O
devastating Reason 3 O O
injury Reason 3 O O
to Reason 3 O O
the Reason 3 O O
brain. Reason 3 O O
[Antibody O O O O
mediated O O O O
IBrainD O O O O
suggested O O O O
treatment O O O O
protocol](/sites/default/files/teams/310/2022_Antibody-Mediated%20Inflammatory%20Brain%20Disease.pdf) O O O O
- O O O O
Rasmussen Reason 3 O O
Encephalitis Reason 3 O O
is Reason 3 O O
a Reason 3 O O
poorly Reason 3 O O
understood Reason 3 O O
disease Reason 3 O O
which Reason 3 O O
causes Reason 3 O O
progressive Reason 3 O O
severe Reason 3 O O
epilepsy. Reason 3 O O
It O O O O
is O O O O
associated O O O O
with O O O O
T-cell O O O O
infiltration O O O O
on O O O O
brain O O O O
biopsy, O O O O
and O O O O
curative O O O O
treatment O O O O
is O O O O
hemispherectomy. O O O O
Medical O O O O
treatment O O O O
is O O O O
usually O O O O
reserved O O O O
for O O O O
older O O O O
children O O O O
and O O O O
individuals O O O O
with O O O O
bilateral O O O O
disease. O O O O
[Rasmussen O O O O
encephalitis O O O O
suggested O O O O
treatment O O O O
protocol](/sites/default/files/teams/310/2022_Rasmussen%20Encephalitis.pdf) O O O O
- O O O O
Transverse Reason 3 O O
Myelitis Reason 3 O O
is Reason 3 O O
a Reason 3 O O
demyelinating Reason 3 O O
disease Reason 3 O O
of Reason 3 O O
the Reason 3 O O
spinal Reason 3 O O
cord, Reason 3 O O
causing Reason 3 O O
paralysis Reason 3 O O
and Reason 3 O O
other Reason 3 O O
neurological Reason 3 O O
dysfunctions, Reason 3 O O
including Reason 3 O O
bowel Reason 3 O O
and Reason 3 O O
bladder Reason 3 O O
dysfunction. Reason 3 O O
Onset O O O O
occurs O O O O
over O O O O
days O O O O
to O O O O
weeks, O O O O
and O O O O
recovery O O O O
usually O O O O
begins O O O O
by O O O O
3 O O O O
months O O O O
after O O O O
starting O O O O
treatment. O O O O
[Transverse O O O O
Myelitis O O O O
suggested O O O O
treatment O O O O
protocol](/sites/default/files/teams/310/2022_Transverse%20Myelitis.pdf) O O O O
- O O O O
Autoimmune Reason 3 O O
Channelopathies Reason 3 O O
are Reason 3 O O
a Reason 3 O O
diverse Reason 3 O O
set Reason 3 O O
of Reason 3 O O
diseases Reason 3 O O
arising Reason 3 O O
from Reason 3 O O
the Reason 3 O O
development Reason 3 O O
auto-antibodies Reason 3 O O
against Reason 3 O O
ion Reason 3 O O
channels Reason 3 O O
in Reason 3 O O
the Reason 3 O O
brain. Reason 3 O O
Disease O O O O
presentation O O O O
is O O O O
dependent O O O O
on O O O O
the O O O O
offending O O O O
antibodies, O O O O
but O O O O
symptoms O O O O
can O O O O
include O O O O
cerebellar O O O O
ataxia O O O O
and O O O O
encephalitis. O O O O
[Autoimmune O O O O
Channelopathies O O O O
suggested O O O O
treatment O O O O
Inflammatory O O O O
Brain O O O O
Diseases O O O O
include O O O O
ANCA-vasculitides O O O O
and O O O O
neurosarcoidosis. O O O O
They O O O O
cause O O O O
a O O O O
wide O O O O
variety O O O O
of O O O O
symptoms O O O O
depending O O O O
on O O O O
the O O O O
localization O O O O
of O O O O
the O O O O
lesions, O O O O
and O O O O
can O O O O
be O O O O
associated O O O O
with O O O O
systemic O O O O
disease O O O O
as O O O O
well. O O O O
[Granulomatous O O O O
IBrainD O O O O
suggested O O O O
treatment O O O O
protocol](/sites/default/files/teams/310/2022_Granulomatous%20Inflammatory%20Brain%20Disease.pdf) O O O O
- O O O O
Suspected Reason 3 O O
Inflammatory Reason 3 O O
Brain Reason 3 O O
Diseases Reason 3 O O
represent Reason 3 O O
a Reason 3 O O
group Reason 3 O O
of Reason 3 O O
diseases Reason 3 O O
in Reason 3 O O
which Reason 3 O O
previously Reason 3 O O
healthy Reason 3 O O
children Reason 3 O O
present Reason 3 O O
with Reason 3 O O
inflammatory Reason 3 O O
brain Reason 3 O O
diseases Reason 3 O O
symptoms Reason 3 O O
but Reason 3 O O
no Reason 3 O O
brain Reason 3 O O
biopsy Reason 3 O O
has Reason 3 O O
been Reason 3 O O
performed Reason 3 O O
to Reason 3 O O
confirm Reason 3 O O
the Reason 3 O O
diagnosis. Reason 3 O O
Affected O O O O
children O O O O
can O O O O
have O O O O
low O O O O
risk, O O O O
intermediate O O O O
risk, O O O O
or O O O O
high O O O O
risk O O O O
disease O O O O
level. O O O O
- O O O O
At O O O O
low O O O O
risk, O O O O
children O O O O
respond O O O O
to O O O O
steroids O O O O
treatment O O O O
immediately O O O O
and O O O O
improve O O O O
without O O O O
in O O O O
need O O O O
of O O O O
a O O O O
second O O O O
line O O O O
agent. O O O O
- O O O O
At O O O O
intermediate O O O O
risk, O O O O
children O O O O
respond O O O O
well O O O O
to O O O O
steroids O O O O
treatment O O O O
along O O O O
with O O O O
second O O O O
line O O O O
agent, O O O O
and O O O O
would O O O O
not O O O O
experience O O O O
life-threatening O O O O
situations. O O O O
- O O O O
At O O O O
high O O O O
risk, O O O O
children O O O O
experience O O O O
symptoms O O O O
similar O O O O
to O O O O
angiography-negative O O O O
CNS O O O O
vasculitis O O O O
(SV-cPACNS), O O O O
but O O O O
they O O O O
do O O O O
not O O O O
have O O O O
brain O O O O
biopsy O O O O
performed O O O O
for O O O O
a O O O O
confirmatory O O O O
diagnosis. O O O O
They O O O O
may O O O O
experience O O O O
life-threatening O O O O
situations O O O O
and O O O O
require O O O O
immediate O O O O
treatment O O O O
if O O O O
possible. O O O O
[Suspected Reason 3 O O
Inflammatory Reason 3 O O
Brain Reason 3 O O
Diseases. Reason 3 O O
